Connect with us

BIOTECH

Vitality Biopharma Inc (OTCMKTS:VBIO) Files Form 10-K

Published

on

Vitality Biopharma Inc

For the year closed March 2017, Vitality Biopharma Inc (OTCMKTS:VBIO) reported revenue of $163,363 compared to revenue of $248,348 in the same period, a year ago. The net loss came at $5.219 million against net loss of $141,325 in the comparable period. Cash used in operations came around $1.384 million in the reported period, compared to approximately $1.685 million in the comparable period, in the previous year.

The details

Vitality reported that it does not expect to raise significant amounts of cash from its ongoing operations for the foreseeable period. These and other factors create substantial doubt about firm’s ability to advance operations smoothly. In addition, the company’s independent registered public accounting company in its report on March 31, 2017 audited fiscal statements, raised considerable doubt about Vitality ability to work as a going concern.

The company will require significant additional funding to advance its business plans and operations and it has no commitments for future capital. Moreover, the continuation of business is dependent upon its ability to sell securities or obtain loans to existing and new investors or get capital from another sources.

Over the next one year following this report date, Vitality intend to increase the scale of its pharmaceutical development measures. As of June 27, 2017, the company reported seven full-time employees. Total expenditures in the coming 12 months are expected to be around $3 million. The company estimate to have sufficient funds to manage its operations for at least 9 months.

However, the total expenditures estimate could increase if the company encounters unanticipated problems. Moreover, the projections of the amount required to fund business may come to be wrong, and the company could spend available financial resources faster than it currently expect.

In the last trading session, the share prices of Vitality gained more than 2% to close the day at $2.15.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement